At Novozymes, our reporting ambition is to provide a report that connects the company’s business model, strategy, targets and performance through integrated financial and sustainability data. We have been working with integrated reporting for many years, as it reflects the way we operate our business.
The Novozymes Report 2013 is available in English in a full online version at www.report2013.novozymes.com and can be accessed via computer, tablet and smartphone. The written online report is complemented by a number of graphics and videos for a full multimedia experience. Additionally, an integrated feature titled My Report enables the reader to compile a full or customized PDF download of the report. We hope that you will find this feature useful, whether printing the report or just saving it on your own computer. The website is fully dedicated to The Novozymes Report 2013 and other information relevant to our shareholders and financial stakeholders, but is also a rich source of information for anyone with an interest in Novozymes.
All photos in the report feature Novozymes employees from around the world, illustrating both our global presence and our human touch. It is our employees who make Novozymes the world leader in bioinnovation.
The website contains The Novozymes Report (which, pursuant to section 149 of the Danish Financial Statements Act, is an extract of the company's annual report) and the financial statements of the parent company Novozymes A/S. Together these form the company’s annual report, which will be filed with the Danish Business Authority.
PwC has audited the consolidated financial statements, the parent company financial statements, and environmental and social data. PwC has also been the sustainability assurance provider and has based the assurance on the AA1000 Assurance Standard (2008).
The audit covers financial, environmental and social data. These are marked “Audited by PwC.” See also the statements in the report.
PwC has not audited the sections of the report found under the headings The Big Picture, Business Review, Strategy & Performance, Governance and Supplementary. Supplementary includes our Communication on Progress with respect to the UN Global Compact principles, our report index based on the Global Reporting Initiative (GRI) and detailed sustainability data from our activities in Argentina, Brazil, Canada, China, Denmark, India, the U.K. and the U.S.
The report has been produced in accordance with International Financial Reporting Standards (IFRS), the Danish Financial Statements Act and the additional requirements of Nasdaq OMX Copenhagen A/S for the presentation of financial statements by listed companies. It has also been prepared as an element of Novozymes' reporting according to the GRI's G3 Sustainability Reporting Guidelines.
The Novozymes Report 2013 contains forward-looking statements, including Novozymes’ financial outlook for 2014, which, by their very nature, are associated with risks and uncertainties that may cause actual results to differ materially from expectations. The uncertainties may include unexpected developments in the international currency exchange and securities markets, market-driven price decreases for Novozymes’ products, changes in regulations and the introduction of competing products in Novozymes’ core areas. See Risk factors & opportunities and Risk management.
|Editor||Julia Bedingfield, Corporate Communications
firstname.lastname@example.org | tel. +45 4446 1724
|Finance||Jens Breitenstein, Finance
email@example.com | tel. +45 4446 1087
|Jan Paulsen, Finance
firstname.lastname@example.org | tel. +45 4446 3208
|Investor Relations||Martin Riise, Investor Relations
email@example.com | tel. +1 919 494 3483
|Sustainability||Mette Halborg, Corporate Sustainability
firstname.lastname@example.org | tel. +45 4446 1853
|Assistance||Tanja Bengtsson, Animal Health & Nutrition
email@example.com | tel. +45 4446 1239
|Text||The editorial team from Novozymes, headed by Corporate Communications|
|Video||Kenneth Aukdal, Novozymes|
|Design & web||Bysted A/S|
|Editing & proofreading
© Novozymes A/S
Novozymes A/S | Krogshoejvej 36 | 2880 Bagsvaerd | Denmark